High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab

High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab

Saved in:

Bibliographic Details
Main Authors:	Ilaria Trave, Ilaria Salvi, Rei Canameri, Carlo Alberto Cutolo, Chiara Bonzano, Matteo Baldi, Carolina Bologna, Gabriele Drago, Giorgio Battaglia, Aurora Parodi, Michele Iester, Emanuele Cozzani
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-08-01
Series:	Acta Dermato-Venereologica
Subjects:	Atopic dermatitis Dupilumab Demodex Conjunctivitis dupilumab Blepharitis
Online Access:	https://medicaljournalssweden.se/actadv/article/view/43322
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis
by: Paulina Stepinska, et al.
Published: (2025-12-01)

Metabolomic and Lipidomic Alterations in Patients with Atopic Dermatitis with Dupilumab-Associated Ocular Surface Disease
by: VijayKumar Patra, et al.
Published: (2025-05-01)

The Demodex Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for Demodex Blepharitis
by: Donnenfeld E, et al.
Published: (2025-06-01)

Global Trends in Studies on the Presence of Demodex spp in Patients Diagnosed with Blepharitis
by: Rahmi Yildiz, et al.
Published: (2024-08-01)

Modern Aspects of Etiopathogenetic Treatment of Ophthalmodemodicosis (Literature Review)
by: A. D. Chuprov, et al.
Published: (2018-07-01)

Effectiveness and safety of dupilumab in the treatment of pediatric atopic dermatitis: a real-world study from China
by: Yue Xu, et al.
Published: (2025-07-01)

Effectiveness and safety of Blefarovit cosmetic product usage in patients with chronic blepharoconjunctivitis and «dry eye» syndrome, combined with an active demodicosis component
by: D.Yu. Maychuk, et al.
Published: (2022-09-01)

Incidence of Conjunctivitis and Keratitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States: a Cohort Study in Routine Care Based on Healthcare Claims
by: Jessica M. Franklin, et al.
Published: (2025-03-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series
by: Sunny B. Patel, et al.
Published: (2025-04-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01)

Effectiveness and safety of demodecosis blepharitis therapy under dry eye conditions
by: S. N. Sakhnov, et al.
Published: (2024-07-01)

Reducing ocular Demodex using petroleum jelly may alleviate dry eye syndrome, blepharitis, facial dermatoses, ocular and respiratory allergies, and decrease associated prescribing: a hypothesis
by: Diana E. Senior-Fletcher, et al.
Published: (2025-08-01)

Successful treatment of scleromyxedema with dupilumab: A case report
by: Abdulelah Alghamdi, MBBS, et al.
Published: (2025-09-01)

A pediatric case of dupilumab-induced pustular psoriasis
by: Nan Dang, et al.
Published: (2024-12-01)

The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)

Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01)

Dupilumab in children and adolescents with atopic dermatitis, a 52-week real-life experience: first report in Colombia
by: Daniela Meléndrez Vásquez, et al.
Published: (2024-10-01)

Response to Comments on The Association of Inflammatory Indexes Derived From Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis [Response to Letter]
by: Zhang L, et al.
Published: (2025-03-01)

Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy
by: Jarmila Čelakovská, et al.
Published: (2025-01-01)

Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01)

Acute generalized exanthematous pustulosis triggered by dupilumab
by: Caterina Mariarosaria Giorgio, et al.
Published: (2025-07-01)

Successful Treatment with Dupilumab of Acquired Reactive Perforating Collagenosis with End-stage Renal Disease
by: Shanglin Jin, et al.
Published: (2025-03-01)

Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
by: Liana Victory, MB, BCh, BAO, MRCPI, et al.
Published: (2025-03-01)

Significance of <i>Demodex folliculorum</i> and <i>Demodex brevis</i> in Pathogenesis of Dermatological Diseases—Current State of Knowledge
by: Katarzyna Rychlik, et al.
Published: (2025-04-01)

Successful Treatment of Pediatric Atopic Prurigo Nodularis with Dupilumab
by: Zhang Y, et al.
Published: (2025-06-01)

Laboratory Changes During Dupilumab Treatment for Atopic Dermatitis
by: D. Flor, et al.
Published: (2025-05-01)

Tumors in the setting of dupilumab use: A review of the literature
by: Shumeng Guo, et al.
Published: (2025-01-01)

Real world evidence of dupilumab effectiveness in a Colombian cohort of patients diagnosed with severe asthma
by: Abraham Alí-Munive, et al.
Published: (2025-05-01)

Clinical-Laboratory Parallels in Patients with Demodectic Blepharitis at Cosmecevtic’s Use
by: I. B. Medvedev, et al.
Published: (2016-01-01)

Could ocular demodicosis be a risk factor for punctal stenosis, dry eye, and blepharitis?
by: Ibrahim Basol, et al.
Published: (2025-04-01)

Cutaneous IgG4-related disease treated with dupilumab
by: Mafalda Pestana, et al.
Published: (2025-04-01)

Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases
by: Yi Jiang, et al.
Published: (2025-12-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Modern Possibilities of Usage Dupilumab in Children
by: Anna A. Kosova, et al.
Published: (2024-12-01)

Dermatitis herpetiformis successfully treated with dupilumab
by: Sara Al-Khawaga, MD, PhD, et al.
Published: (2025-07-01)

Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results
by: Margaret H. Collins, et al.
Published: (2025-01-01)